Comparison of Clinicopathologic Parameters and Survivals Between Epstein-Barr Virus-positive and Her2-positive Gastric Cancers von Irkkan, Cigdem, Balci, Serdar, Güler Tezel, Gaye, Akinci, Bülent, Yalcin, Bülent, Güler, Gülnur

Volltext

The prognostic value of UHRF-1 and p53 in gastric cancer von Babacan, Nalan A, Egilmez, Hatice Reyhan, Yücel, Birsen, Ilknur, Parlak, Seker, Mehmet Metin, Kacan, Turgut, Bahceci, Aykut, Cihan, Sener, Akinci, Bülent, Eriten, Berna, Kilickap, Saadettin

Volltext

A current comprehensive role of immune-checkpoint inhibitors in resectable non-small cell lung cancer: A narrative review von Efil, Safa Can, Bilgin, Burak, Ceylan, Furkan, Karakaş, Hilal, Karahan, İrfan, Özsan, Sema Nur, Kosku, Hakan, Yaman, Şebnem, Bülent Akıncı, Muhammed, Dede, Didem Şener, Yalçın, Bülent, Nahit Şendur, Mehmet Ali

Volltext

Prognostic effect of red cell distribution width-to-platelet ratio in colorectal cancer according to tumor stage and localization von Bilgin, Burak, Sendur, Mehmet, Hizal, Mutlu, Dede, Didem, Akinci, Muhammed, Kandil, Sümeyye, Yaman, Samet, Yalçin, Abdussamet, Kiliç, Mehmet, Yalçin, Bülent

Volltext

Clinicopathological and survival features of neuroendocrine tumors: A retrospective analysis of 153 cases, our current remarks on a heterogeneous tumor group, and still unmet futur... von Kahraman, Seda, Bardakci, Murat, Aykan, Musa B, Yasar, Serkan, Erol, Cihan, Hizal, Mutlu, Akinci, M Bulent, Kos, Fahriye Tugba, Kos, Tugba, Dede, Didem S, Karadurmus, Nuri, Yalcin, Suayib, Sendur, Mehmet Ali Nahit, Yalcin, Bulent

Volltext

Optimal regimen for treatment-naive hormone receptor-positive HER-2 negative metastatic breast cancer von Bilgin, Burak, endur, Mehmet AN, H zal, Mutlu, Ak nc, Muhammed Bülent, Dede, Didem ener, Yalç n, Bülent

Volltext

The association of clinicopathologic features and peripheral blood parameters with high PD-L1 expression in non-small cell lung cancer von Bilgin, Burak, Hızal, Mutlu, Yücel, Şebnem, Şendur, Mehmet Ali Nahit, Akyürek, Nalan, Akıncı, Muhammed Bülent, Yılmaz, Ülkü, Yalçın, Bülent

Volltext

Do tyrosine kinase inhibitors lose favor in treatment of first-line metastatic renal cell carcinoma? von Yaman, Samet, Bilgin, Burak, endur, Mehmet AN, H zal, Mutlu, Ak nc, Muhammed Bülent, Yalç n, Bulent

Volltext

Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group) von EROL, CİHAN, SAKİN, ABDULLAH, TÜYLÜ, TUĞBA BAŞOĞLU, ÖZDEN, ERCAN, ÇABUK, DEVRİM, DOĞAN, MUTLU, ÖKSÜZOĞLU, ÖMÜR BERNA ÇAKMAK, YILDIRIM, HASAN ÇAĞRI, ÖNER, İREM, ERYILMAZ, MELEK KARAKURT, DÜLGAR, ÖZGECAN, AYDIN, DİNÇER, ÖZYURT, NESLİHAN, ÖZEN, MİRAÇ, HACIBEKİROĞLU, İLHAN

Volltext

Docetaxel or abiraterone in addition to androgen deprivation therapy in metastatic castration-sensitive prostate cancer von Bilgin, Burak, endur, Mehmet AN, H zal, Mutlu, Ak nc, Muhammed Bülent, ener Dede, Didem, Yalç n, Bulent

Volltext

Clinical features of the ALK-mutant non-small cell lung cancer patients who received first-line alectinib treatment von Hızal, Mutlu, Bilgin, Burak, Şendur, Mehmet Ali, Yücel, Şebnem, Kahraman, Seda, Erol, Cihan, Akıncı, Bülent, Şener Dede, Didem, Algın, Efnan, Yalçın, Bülent

Volltext

The current status of adjuvant treatment for high-risk renal cell carcinoma von H zal, Mutlu, endur, Mehmet AN, Bilgin, Burak, Ak nc, Muhammed Bülent, ener Dede, Didem, Yalç n, Bulent

Volltext

Do all aromatase inhibitors have similar efficacy and safety? von endur, Mehmet AN, Bilgin, Burak, H zal, Mutlu, Özdemir, Nuriye Y ld r m, Ak nc, Muhammed Bülent, Dede, Didem ener, Yalç n, Bulent

Volltext

Is exon mutation analysis needed for adjuvant treatment of gastrointestinal stromal tumor? von Sendur, Mehmet Ali Nahit, Ozdemir, Nuriye Yildirim, Akinci, Muhammed Bülent, Uncu, Dogan, Zengin, Nurullah, Aksoy, Sercan

Volltext

Role of obesity on the efficacy of exemestane plus ovarian suppression in hormone receptor-positive premenopausal breast cancer von endur, Mehmet Ali Nahit, Aksoy, Sercan, Bülent Ak nc, Muhammed, Ozdemir, Nuriye, ener Dede, Didem, Altundag, Kadri, Zengin, Nurullah, Yalç n, Bülent

Volltext

Actual benefit of chemo-hormonal therapy in non-castrate metastatic prostate cancer von endur, Mehmet AN, Ak nc, Muhammed Bülent, Ozdemir, Nuriye Y ld r m, Aksoy, Sercan, Dede, Didem S, Ulas, Arife, Zengin, Nurullah, Yalç n, Bülent

Volltext

Adding Chemotherapy After Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer; Promising or not? von NAHIT SENDUR, MEHMET ALI

Volltext

The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement von Bilgin, Burak, Şendur, Mehmet Ali Nahit, Yücel, Şebnem, Hizal, Mutlu, Güner, Gürkan, Akyürek, Nalan, Erol, Cihan, Akıncı, Muhammed Bülent, Dede, Didem Şener, Yalçın, Bülent, Kılıçkap, Sadettin

Volltext

Does Zoledronic Acid Have Additive Effect on Suppression of Plasma Estrogen Levels ? von Sendur, Mehmet Ali Nahit, Aksoy, Sercan, Ozdemir, Nuriye Yildirim, Akinci, Muhammed Bulent, Zengin, Nurullah, Altundag, Kadri

Volltext

The relationship between adjuvant chemotherapy and thiol-disulfide compounds von Akyol, Pınar, Dede, Didem, Bilgin, Burak, Ulaş, Arife, Nahit Şendur, Mehmet, Akıncı, Muhammed, Başer, Salih, Erol, Cihan, Hızal, Mutlu, Yalçın, Bülent

Volltext